Rockwell Medical, Inc. (RMTI) vs Scilex Holding Company (SCLX)

A side-by-side comparison of Rockwell Medical, Inc. and Scilex Holding Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — RMTI vs SCLX

growth of $100 · dividends reinvested · last 6y
RMTI -94.7% (-38.6%/yr)SCLX -98.9% (-52.8%/yr)RMTI compounded faster over this window
050100150Start $10020222023202420252026$5$1
RMTI SCLX

RMTI vs SCLX: by the numbers

  • •SCLX is the larger company ($34M vs $32M market cap).
  • •Both run net losses; RMTI's is the smaller (-7.33% vs -1414.57% net margin).
  • •SCLX grew revenue faster over the past five years (3.58% vs 2.59% CAGR).

Metrics side by side

Valuation

MetricRMTISCLX
P/S ratio0.461.06
P/B ratio0.92N/A
FCF yield4.79%N/A

Profitability

MetricRMTISCLX
Gross margin17.71%49.68%
Operating margin-6.52%-903.52%
Net margin-7.33%-1414.57%
ROE-14.49%N/A
ROIC-9.60%N/A

Growth (annualized)

MetricRMTISCLX
Revenue CAGR (5Y)2.59%3.58%
Total return CAGR (5Y)-33.38%-59.50%

Frequently asked

Which has grown faster, RMTI or SCLX?
Over the past five years, SCLX grew revenue faster — RMTI at a 2.59% CAGR versus SCLX at 3.58%.
How have RMTI and SCLX total returns compared?
Over the past 5 years, RMTI delivered -33.38% and SCLX delivered -59.50% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.